ADMA Biologics
ADMA
ADMA
105 hedge funds and large institutions have $85.4M invested in ADMA Biologics in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
7.68% less ownership
Funds ownership: 47.71% → 40.03% (-7.7%)
60% less call options, than puts
Call options by funds: $1.53M | Put options by funds: $3.79M
Holders
105
Holding in Top 10
–
Calls
$1.53M
Puts
$3.79M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$1.32M | |
| 3 | +$956K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$856K |
| 5 |
Squarepoint
New York
|
+$798K |
Top Sellers
| 1 | -$4.86M | |
| 2 | -$3.9M | |
| 3 | -$3.04M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.22M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$1.05M |